Comment on page
BLOCKCHAIN BIOPHARMA: INVESTMENT GOALS AND CRITERIA DATA
Investment will go toward software development, #Data Collection operations, digital advertising, regulatory and compliance for a global scale, liquidity, and market maker services.
Currently, we are working to integrate 26 different global derivative and cryptocurrency trading platforms to list our Pharmaceutical Token (Ticker: PHARMA)
We have selected #Consensys's MetaMask Institutional Account, and several other high-security / high-quality Crypto Wallets to safely store Pharmaceutical Tokens (Ticker: PHARMA), including cold-storage.
- MINIMUM NEEDED FOR COMMERCIAL VIABILITY
- $25 Million
- MAXIMUM NEEDED FOR CROWD FUNDING SERIES A, B, C
- $300 Million
- $25 MM Seed Round
- Investors will be granted voting rights in the DAO, powered by transparent Voting Smart Contracts. Collaboration in this early stage is critical, and we seek partners with a vested interest in the success of Blockchain BioPharma's #Mission. We want only high performers.
- MINIMUM TOKEN PRICING FOR ENTERPRISES:
- $6.00 - 1 Million PHARMA Tokens Purchased
- $5.00 - 2 Million PHARMA Tokens Purchased
- $4.00 - 3 Million PHARMA Tokens Purchased
- CASH FLOW REQUIREMENTS WITH $20(M) INVESTMENT MINIMUM
- [$500(k)] = Monthly Startup Burn Data (Platform Development, Advertising / Partnership Development, Survey, Research & Development, and Scrum Team)
- [$250(k)] = Remaining Regulatory Licensing Costs
- [$100,000(k)] = Approximate 3rd - Party Data Providers
Software Products & Services
WE DO NOT MAKE INVESTMENT RETURN PROMISES THUS NO PRO-FORMAS. WE ONLY PRESENT EXISTING QUALITATIVE AND QUANTITAVE DATA AVAILABLE
CRYPTO IS A RISKY BUSINESS – LASTLY, VOTERS IN OUR DECENTRALIZED AUTONOMOUS ORGANIZATION WILL INFORM THE BUSINESS, eNFT INVESTMENT, AND MANAGEMENT DECISIONS - TARGET DATE Q2 2022.
The US Treasure Departments Stablecoin Analysis